These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 9548395)
21. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia. von Euler M; Seiger A; Holmberg L; Sundström E Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838 [TBL] [Abstract][Full Text] [Related]
22. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. Kenny PJ; Gasparini F; Markou A J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481 [TBL] [Abstract][Full Text] [Related]
23. Interactions between NMDA and AMPA glutamate receptor antagonists during halothane anesthesia in the rat. McFarlane C; Warner DS; Dexter F Neuropharmacology; 1995 Jun; 34(6):659-63. PubMed ID: 7566502 [TBL] [Abstract][Full Text] [Related]
24. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. Nellgård B; Wieloch T J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757 [TBL] [Abstract][Full Text] [Related]
27. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat. Yokoyama O; Mizuno H; Komatsu K; Akino H; Tanase K; Namiki M J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271 [TBL] [Abstract][Full Text] [Related]
28. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat. Kodama M; Yamada N; Sato K; Kitamura Y; Koyama F; Sato T; Morimoto K; Kuroda S Eur J Pharmacol; 1999 Jun; 374(1):11-9. PubMed ID: 10422635 [TBL] [Abstract][Full Text] [Related]
29. In vivo and in vitro evaluation of AMPA receptor antagonists in rat hippocampal neurones and cultured mouse cortical neurones. Mathiesen C; Varming T; Jensen LH Eur J Pharmacol; 1998 Jul; 353(2-3):159-67. PubMed ID: 9726646 [TBL] [Abstract][Full Text] [Related]
30. Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats. Kawasaki-Yatsugi S; Shimizu-Sasamata M; Yatsugi S; Yamaguchi T J Pharm Pharmacol; 1998 Aug; 50(8):891-8. PubMed ID: 9751454 [TBL] [Abstract][Full Text] [Related]
31. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo. Sato K; Morimoto K; Yamada N; Kuroda S; Hayabara T Brain Res; 1995 Jun; 683(2):279-82. PubMed ID: 7552367 [TBL] [Abstract][Full Text] [Related]
32. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors. Mead AN; Stephens DN J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753 [TBL] [Abstract][Full Text] [Related]
33. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Sheardown MJ; Suzdak PD; Nordholm L Eur J Pharmacol; 1993 Jun; 236(3):347-53. PubMed ID: 7689464 [TBL] [Abstract][Full Text] [Related]
34. NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D(2/3) dopamine receptor stimulation in rats. Biondo AM; Clements RL; Hayes DJ; Eshpeter B; Greenshaw AJ Psychopharmacology (Berl); 2005 Apr; 179(1):189-97. PubMed ID: 15744543 [TBL] [Abstract][Full Text] [Related]
35. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397 [TBL] [Abstract][Full Text] [Related]
36. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices. Lockhart B; Iop F; Closier M; Lestage P Eur J Pharmacol; 2000 Aug; 401(2):145-53. PubMed ID: 10924919 [TBL] [Abstract][Full Text] [Related]
37. Combined blockade of NMDA and non-NMDA receptors produces respiratory arrest in the adult cat. Foutz AS; Pierrefiche O; Denavit-Saubié M Neuroreport; 1994 Jan; 5(4):481-4. PubMed ID: 8003680 [TBL] [Abstract][Full Text] [Related]
38. NMDA but not AMPA receptor antagonists impair the delay-interposed radial maze performance of rats. Li HB; Matsumoto K; Yamamoto M; Watanabe H Pharmacol Biochem Behav; 1997 Sep; 58(1):249-53. PubMed ID: 9264099 [TBL] [Abstract][Full Text] [Related]
39. NMDA receptors mediate peripheral chemoreceptor afferent input in the conscious rat. Ohtake PJ; Torres JE; Gozal YM; Graff GR; Gozal D J Appl Physiol (1985); 1998 Mar; 84(3):853-61. PubMed ID: 9480943 [TBL] [Abstract][Full Text] [Related]
40. NMDA-but not AMPA-receptor antagonists augment scopolamine-induced spatial cognitive deficit of rats in a radial maze task. Li HB; Matsumoto K; Tohda M; Yamamoto M; Watanabe H Brain Res; 1996 Jul; 725(2):268-71. PubMed ID: 8836535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]